Evidence map›Paper›PMID 32200535›Full record

ReviewAdvances in therapy2020

New Perspectives for Mucolytic, Anti-inflammatory and Adjunctive Therapy with 1,8-Cineole in COPD and Asthma: Review on the New Therapeutic Approach.

Lisa Joy Juergens, Heinrich Worth, Uwe R Juergens

Open access · hybridAbstract readReview
In one paragraph

Review in Advances in therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Chemical Composition ofMolecules (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Overview of Research on Essential Oils ofPharmaceuticals (Basel, Switzerland) · 2026
    Review
  9. Article
  10. Metabolic engineering ofFrontiers in microbiology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Effect of eucalyptus oil on symptoms of allergic rhinitis: a systematic review.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025
    Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Commented on by
    2021
  • Commented on by
    2021
5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Lisa Joy JuergensMedical University of Tübingen, Medical School, 72070, Tübingen, Germany.
Heinrich WorthSpecialist Forum Fürth, 90762, Fürth, Germany.
Uwe R JuergensDepartment of Pulmonary Rehabilitation, Asklepios Nordseeklinik Westerland, Norderstraße 81, 25980, Sylt, Germany. Uw.Juergens@asklepios.com.
Asklepios Kliniken Hamburg · DEKlinikum Fürth · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mucolytic monoterpene 1,8-cineole (eucalyptol), the major constituent of eucalyptus species, is well known for its anti-inflammatory, antioxidant, bronchodilatory, antiviral and antimicrobial effects. The main protective antiviral, anti-inflammatory and mucolytic mechanisms of 1,8-cineole are the induction of interferon regulatory factor 3 (IRF3), the control of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) along with decreasing mucin genes (MUC2, MUC19). In normal human monocytes direct inhibition was shown of reactive oxygen species (ROS)-mediated mucus hypersecretion and of steroid resistence inducing superoxides (O

Indexed as

Administration, InhalationAdultAgedAged, 80 and overAnti-Inflammatory AgentsAntitussive AgentsEucalyptolExpectorantsFemaleFormoterol FumarateHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveAnti-Inflammatory AgentsAntitussive AgentsEucalyptolExpectorantsFormoterol Fumarate1,8-CineoleAsthmaChronic obstructive pulmonary disease (COPD)MucolyticsSinusitis

Identifiers

PMID32200535
PMCPMC7467491
OpenAlexW3012255538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.